Acquisition leverage GlobalCare has joined Covance to expand decentralized clinical trial capabilities globally, presenting a cross-sell opportunity to Covance clients seeking broader DCT reach and patient-centric designs.

DCT expertise As a recognized leader in patient-centric decentralized trials, GlobalCare complements Covance’s portfolio, enabling targeted outreach to sponsors prioritizing faster patient enrollment, diverse site access, and remote-site feasibility.

Tech stack synergy Utilize GlobalCare’s and Covance’s combined tech ecosystem (Azure, SAP, Anaplan, AEM) to offer integrated data platforms, scalable analytics, and streamlined trial operations that appeal to sponsors aiming for end-to-end digital trial solutions.

Growth opportunities With GlobalCare’s footprint and Covance’s global reach, prospects in regions with growing clinical activity can be engaged for co-developed global DCT programs, potentially increasing study speed and patient engagement metrics.

Financial & partnership signals The collaboration aligns with market momentum toward outsourcing and modernized trial designs; targeted outreach to mid-to-large sponsors seeking scalable DCT implementations and risk-sharing partnerships could yield high-value engagements.